VVVVVVVV VEDA
LIVE

Serial Number

98423612

Owner

Veda Life Sciences, Inc.

Attorney

Elizabeth Oliner

Filing Date

Feb 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VVVVVVVV VEDA Trademark

Serial Number: 98423612 • Registration: 8356643

VVVVVVVV VEDA is a trademark filed by Veda Life Sciences, Inc. on February 27, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Veda Life Sciences, Inc. (5 trademarks)

5557 Urbana Pike #1123
Frederick, MD 21704

Entity Type: 03

Trademark Details

Filing Date

February 27, 2024

Registration Date

July 21, 2026

Published for Opposition

May 6, 2025

Goods & Services

Platform as a service (PAAS) featuring computer software platforms for use in providing back-end automation features to assist in onboarding new clinical trial sites and healthcare providers for facilitating and enabling recruitment of participants for use in running, managing and analyzing clinical trials, namely enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for management and/or participation in clinical research in the nature of database creation and selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communication, data entry, regulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community based healthcare organizations and clinical trial sponsors for use in clinical research analytics, data capture forms, management, viewing data analytics, enabling site data capture; selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communication, data entry, regulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community- based healthcare organizations and clinical trial sponsors for use in clinical research analytics, data capture forms, electronic clinical outcome assessment, recruitment, and electronic consent; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 30, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 30, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 8, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 7, 2026 AITU
USE AMENDMENT FILED
Feb 18, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 18, 2026 EISU
POST PUBLICATION AMENDMENT - ENTERED
Jan 21, 2026 CHPB
ASSIGNED TO PETITION STAFF
Jan 13, 2026 APET
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 30, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 13, 2025 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 8, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
May 28, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 29, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 24, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 24, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 24, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 8, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2024 NWOS
NEW APPLICATION ENTERED
Feb 27, 2024 NWAP